Breaking down brain barrier breaches in cerebral malaria
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
Breaking down brain barrier breaches in cerebral malaria. / Petersen, Jens E V; Lavstsen, Thomas; Craig, Alister.
In: Journal of Clinical Investigation, Vol. 126, No. 10, 03.10.2016, p. 3725-3727.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Breaking down brain barrier breaches in cerebral malaria
AU - Petersen, Jens E V
AU - Lavstsen, Thomas
AU - Craig, Alister
PY - 2016/10/3
Y1 - 2016/10/3
N2 - Recent findings have linked brain swelling to death in cerebral malaria (CM). These observations have prompted a number of investigations into the mechanisms of this pathology with the goal of identifying potential therapeutic targets. In this issue of the JCI, Gallego-Delgado and colleagues present evidence that implicates angiotensin receptors and the relocation of β-catenin to the endothelial cell nucleus in CM. This study provides a renewed focus on infected erythrocyte debris as the cause of endothelial damage and challenges previous work implicating direct effects of infected erythrocyte sequestration in the brain as the major driver of disease. While this work provides potential therapeutic avenues for CM, it leaves a number of questions unanswered.
AB - Recent findings have linked brain swelling to death in cerebral malaria (CM). These observations have prompted a number of investigations into the mechanisms of this pathology with the goal of identifying potential therapeutic targets. In this issue of the JCI, Gallego-Delgado and colleagues present evidence that implicates angiotensin receptors and the relocation of β-catenin to the endothelial cell nucleus in CM. This study provides a renewed focus on infected erythrocyte debris as the cause of endothelial damage and challenges previous work implicating direct effects of infected erythrocyte sequestration in the brain as the major driver of disease. While this work provides potential therapeutic avenues for CM, it leaves a number of questions unanswered.
U2 - 10.1172/JCI90188
DO - 10.1172/JCI90188
M3 - Comment/debate
C2 - 27643435
VL - 126
SP - 3725
EP - 3727
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
SN - 0021-9738
IS - 10
ER -
ID: 167362381